Paper41563447
Targeting STAT3 by SH-4-54 suppresses the occurrence and inactivates oxidative phosphorylation in small-cell lung cancer via the SRC signaling.
Chen C and 4 others. Naunyn Schmiedebergs Arch Pharmacol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Targeting STAT3 by SH-4-54 suppresses the occurrence and inactivates oxidative phosphorylation in small-cell lung cancer via the SRC signaling. Papers, record 41563447. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41563447
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeting STAT3 by SH-4-54 suppresses the occurrence and inactivates oxidative phosphorylation in small-cell lung cancer via the SRC signaling.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| STAT3 Transcription Factor | Major topic |
| Lung Neoplasms | Major topic |
| Small Cell Lung Carcinoma | Major topic |
| Antineoplastic Agents | Major topic |
| src-Family Kinases | Major topic |
| Animals | |
| Humans | |
| Signal Transduction | |
| Cell Line, Tumor | |
| Apoptosis | |
| Cell Proliferation | |
| Mice, Nude | |
| Oxidative Phosphorylation | |
| Cisplatin | |
| Xenograft Model Antitumor Assays | |
| Mice, Inbred BALB C | |
| Mice | |
| Molecular Docking Simulation | |
| Male |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| YCBE202213 | Science and Technology Bureau of Yancheng City in 2022 | PubMed |
Source PubMed
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31378235 | Current Diagnosis and Management of Small-Cell Lung Cancer. | Mayo Clin Proc | 2019 | https://conductscience.org/library/papers/31378235 | PubMed |
| 2 | 26649644 | Non-canonical Stat3 signaling in cancer. | Mol Carcinog | 2016 | https://conductscience.org/library/papers/26649644 | PubMed |
| 3 | 31085234 | Hydrogen sulphide mitigates homocysteine-induced apoptosis and matrix remodelling in mesangial cells through Akt/FOXO1 signalling cascade. | Cell Signal | 2019 | https://conductscience.org/library/papers/31085234 | PubMed |
| 4 | 36193770 | Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling. | Thorac Cancer | 2022 | https://conductscience.org/library/papers/36193770 | PubMed |
| 5 | 32871210 | NOK associates with c-Src and promotes c-Src-induced STAT3 activation and cell proliferation. | Cell Signal | 2020 | https://conductscience.org/library/papers/32871210 | PubMed |
| 6 | 32466572 | The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC). | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32466572 | PubMed |
| 7 | 29861494 | Src Cooperates with Oncogenic Ras in Tumourigenesis via the JNK and PI3K Pathways in Drosophila epithelial Tissue. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29861494 | PubMed |
| 8 | 25625009 | Protein phosphatase 2C-alpha knockdown reduces angiotensin II-mediated skeletal muscle wasting via restoration of mitochondrial recycling and function. | Skelet Muscle | 2014 | https://conductscience.org/library/papers/25625009 | PubMed |
| 9 | 32165236 | STAT3 inhibition induced temozolomide-resistant glioblastoma apoptosis via triggering mitochondrial STAT3 translocation and respiratory chain dysfunction. | Cell Signal | 2020 | https://conductscience.org/library/papers/32165236 | PubMed |
| 10 | 39964764 | Super-enhancer-driven EFNA1 fuels tumor progression in cervical cancer via the FOSL2-Src/AKT/STAT3 axis. | J Clin Invest | 2025 | https://conductscience.org/library/papers/39964764 | PubMed |
| 11 | 39995553 | Targeting STAT3 with SH-4-54 suppresses stemness and chemoresistance in cancer stem-like cells derived from colorectal cancer. | World J Clin Oncol | 2025 | https://conductscience.org/library/papers/39995553 | PubMed |
| 12 | 36284389 | Asiaticoside Prevents Oxidative Stress and Apoptosis in Endothelial Cells by Activating ROS-dependent p53/Bcl-2/Caspase-3 Signaling Pathway. | Curr Mol Med | 2023 | https://conductscience.org/library/papers/36284389 | PubMed |
| 13 | 11114744 | Role of Src expression and activation in human cancer. | Oncogene | 2000 | https://conductscience.org/library/papers/11114744 | PubMed |
| 14 | 35671760 | Lung Cancer: Epidemiology and Screening. | Surg Clin North Am | 2022 | https://conductscience.org/library/papers/35671760 | PubMed |
| 15 | 36839692 | Comparative Analysis of Dasatinib Effect between 2D and 3D Tumor Cell Cultures. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36839692 | PubMed |
| 16 | 23807222 | Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2. | Cell Death Dis | 2013 | https://conductscience.org/library/papers/23807222 | PubMed |
| 17 | 29115375 | Persistent STAT5-mediated ROS production and involvement of aberrant p53 apoptotic signaling in the resistance of chronic myeloid leukemia to imatinib. | Int J Mol Med | 2018 | https://conductscience.org/library/papers/29115375 | PubMed |
| 18 | 31069881 | Aminocyanopyridines as anti-lung cancer agents by inhibiting the STAT3 pathway. | Mol Carcinog | 2019 | https://conductscience.org/library/papers/31069881 | PubMed |
| 19 | 35559870 | Impact of the National Lung Screening Trial (NLST) publication and Medicare Lung cancer screening payment on lung cancer incidence rates: An interrupted time series analysis. | J Cancer Policy | 2022 | https://conductscience.org/library/papers/35559870 | PubMed |
| 20 | 35770045 | Aberrant ROS Served as an Acquired Vulnerability of Cisplatin-Resistant Lung Cancer. | Oxid Med Cell Longev | 2022 | https://conductscience.org/library/papers/35770045 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41563447
GET https://conductscience.org/api/papers/v1/41563447/references?page=2